Literature DB >> 11320224

Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization.

F C Yang1, S J Atkinson, Y Gu, J B Borneo, A W Roberts, Y Zheng, J Pennington, D A Williams.   

Abstract

Critical to homeostasis of blood cell production by hematopoietic stem/progenitor (HSC/P) cells is the regulation of HSC/P retention within the bone marrow microenvironment and migration between the bone marrow and the blood. Key extracellular regulatory elements for this process have been defined (cell-cell adhesion, growth factors, chemokines), but the mechanism by which HSC/P cells reconcile multiple external signals has not been elucidated. Rac and related small GTPases are candidates for this role and were studied in HSC/P deficient in Rac2, a hematopoietic cell-specific family member. Rac2 appears to be critical for HSC/P adhesion both in vitro and in vivo, whereas a compensatory increase in Cdc42 activation regulates HSC/P migration. This genetic analysis provides physiological evidence of cross-talk between GTPase proteins and suggests that a balance of these two GTPases controls HSC/P adhesion and mobilization in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11320224      PMCID: PMC33261          DOI: 10.1073/pnas.101546898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  The hematopoietic microenvironment.

Authors:  J S Greenberger
Journal:  Crit Rev Oncol Hematol       Date:  1991       Impact factor: 6.312

2.  Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia.

Authors:  C D Nobes; A Hall
Journal:  Cell       Date:  1995-04-07       Impact factor: 41.582

3.  Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin.

Authors:  T Papayannopoulou; B Nakamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

4.  Episomal vectors rapidly and stably produce high-titer recombinant retrovirus.

Authors:  T M Kinsella; G P Nolan
Journal:  Hum Gene Ther       Date:  1996-08-01       Impact factor: 5.695

5.  Real time quantitative PCR.

Authors:  C A Heid; J Stevens; K J Livak; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

Review 6.  Homing and trafficking of hemopoietic progenitor cells.

Authors:  T Papayannopoulou; C Craddock
Journal:  Acta Haematol       Date:  1997       Impact factor: 2.195

Review 7.  Regulation of cellular signalling by fatty acid acylation and prenylation of signal transduction proteins.

Authors:  M D Resh
Journal:  Cell Signal       Date:  1996-09       Impact factor: 4.315

Review 8.  Rho family members: activators of MAP kinase cascades.

Authors:  A B Vojtek; J A Cooper
Journal:  Cell       Date:  1995-08-25       Impact factor: 41.582

9.  The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen.

Authors:  T Papayannopoulou; C Craddock; B Nakamoto; G V Priestley; N S Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

10.  A new direct-viewing chemotaxis chamber.

Authors:  D Zicha; G A Dunn; A F Brown
Journal:  J Cell Sci       Date:  1991-08       Impact factor: 5.285

View more
  75 in total

1.  The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation.

Authors:  Benjamin Mizukawa; Eric O'Brien; Daniel C Moreira; Mark Wunderlich; Cindy L Hochstetler; Xin Duan; Wei Liu; Emily Orr; H Leighton Grimes; James C Mulloy; Yi Zheng
Journal:  Blood       Date:  2017-08-04       Impact factor: 22.113

2.  On how Rac controls hematopoietic stem cell activity.

Authors:  J A Cancelas
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

3.  Rac signaling in osteoblastic cells is required for normal bone development but is dispensable for hematopoietic development.

Authors:  Steven W Lane; Serena De Vita; Kylie A Alexander; Ruchan Karaman; Michael D Milsom; Adrienne M Dorrance; Amy Purdon; Leeann Louis; Mary L Bouxsein; David A Williams
Journal:  Blood       Date:  2011-11-28       Impact factor: 22.113

4.  Signaling and cytoskeletal requirements in erythroblast enucleation.

Authors:  Diamantis G Konstantinidis; Suvarnamala Pushkaran; James F Johnson; Jose A Cancelas; Stefanos Manganaris; Chad E Harris; David A Williams; Yi Zheng; Theodosia A Kalfa
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

Review 5.  Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells.

Authors:  Aysegul Ocal Sahin; Miranda Buitenhuis
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

6.  Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin alpha4beta1.

Authors:  David García-Bernal; Natalia Wright; Elena Sotillo-Mallo; César Nombela-Arrieta; Jens V Stein; Xosé R Bustelo; Joaquin Teixidó
Journal:  Mol Biol Cell       Date:  2005-05-04       Impact factor: 4.138

Review 7.  The stem cell niches in bone.

Authors:  Tong Yin; Linheng Li
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

8.  Rac GTPases regulate the morphology and deformability of the erythrocyte cytoskeleton.

Authors:  Theodosia A Kalfa; Suvarnamala Pushkaran; Narla Mohandas; John H Hartwig; Velia M Fowler; James F Johnson; Clinton H Joiner; David A Williams; Yi Zheng
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

9.  Calcium mobilization and Rac1 activation are required for VCAM-1 (vascular cell adhesion molecule-1) stimulation of NADPH oxidase activity.

Authors:  Joan M Cook-Mills; Jacob D Johnson; Tracy L Deem; Atsuo Ochi; Lei Wang; Yi Zheng
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

Review 10.  Rho GTPases in hematopoiesis and hemopathies.

Authors:  James C Mulloy; Jose A Cancelas; Marie-Dominique Filippi; Theodosia A Kalfa; Fukun Guo; Yi Zheng
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.